Penumbra, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 13G, Stake over 5%, passiveAug 13 →InsidersNo open-market buys. 5 insiders sold $11.1M, all 32 sales on a 10b5-1 plan.→HoldersBlackRock 11.0%HBK Investments L P 4.7%Vanguard 4.4%→PeersClosest companies: GMED, CLPT, BVS→
From the filings
Figures
- Revenue
- $1.50Blast 12 months
- Net income
- $160.6Mlast 12 months
- Operating cash flow
- $276.7Mlast 12 months
- Cash and equivalents
- $205.3Mat the last balance sheet
- Shares outstanding
- 39.2M shareson issue